BioSpace News Archive

Following the closure of several research programs for Alzheimer’s disease, in early 2018 the FDA issued a release entitled “Draft Guidance for Industry: Early Alzheimer’s Disease: Developing Drugs for Treatment.”

Studies Show Significantly Reduced Complications, Improved Service Capacity, and Decreased Costs

Mallinckrodt Pharmaceuticals announced today that it will report third quarter fiscal 2018 earnings results for the period ending Sept. 28, 2018, on Tuesday, Nov. 6, 2018.

MaRS Discovery District, together with its partner University of Toronto, today announced that it is in the final stages of securing a lease with Menkes Developments Ltd. (“Menkes”) for a new 24,000-square-foot hub at Toronto’s Waterfront Innovation Centre.

Award recognizes excellence and innovation in spine surgery products

The company will present at the Ladenburg Thalmann 2018 Healthcare Conference on October 2, 2018 at 12:00 pm Eastern Time in New York, NY.

Newron is a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system.

Interactive Health today announced it has received the highest accreditation from the National Committee for Quality Assurance (NCQA) in the category of “Wellness and Health Promotion with Performance Reporting.”

OncoSec Medical Incorporated (OncoSec) (NASDAQ: ONCS), a company developing intratumoral cancer immunotherapies, today announced that Daniel J. O’Connor, President and Chief Executive Officer of OncoSec, will present a corporate overview at the Cantor Fitzgerald Global Healthcare Conference on Monday, October 1, 2018 at 4:05 p.m. ET in New York City.

Tris Pharma, Inc., (Tris), a pharmaceutical company focused on developing innovative technology-based therapeutic products that address unmet patient needs, today announced the acquisition of NextWave Pharmaceuticals (NextWave), a wholly owned subsidiary of Pfizer Inc. (Pfizer), including two key Attention Deficit Hyperactivity Disorder (ADHD) treatments.